Opioids for chronic non-cancer pain.
作者信息
Gallagher H, Galvin D
机构信息
St Vincent's University Hospital, Dublin, Ireland.
出版信息
BJA Educ. 2018 Nov;18(11):337-341. doi: 10.1016/j.bjae.2018.06.006. Epub 2018 Sep 27.
Abstract
摘要
相似文献
1
Opioids for chronic non-cancer pain.
BJA Educ. 2018 Nov;18(11):337-341. doi: 10.1016/j.bjae.2018.06.006. Epub 2018 Sep 27.
2
Opioids for chronic non-cancer pain in children and adolescents.
Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD012538. doi: 10.1002/14651858.CD012538.pub2.
3
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
Pain Physician. 2012 Jul;15(3 Suppl):S1-65.
4
Breakthrough pain in chronic non-cancer pain: fact, fiction, or abuse.
Pain Physician. 2011 Mar-Apr;14(2):E103-17.
5
Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Pain Physician. 2017 Feb;20(2S):S3-S92.
6
Non-analgesic effects of opioids: the cognitive effects of opioids in chronic pain of malignant and non-malignant origin. An update.
Curr Pharm Des. 2012;18(37):6116-22. doi: 10.2174/138161212803582522.
7
The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids.
Int J Clin Pract. 2015 Nov;69(11):1366-76. doi: 10.1111/ijcp.12716. Epub 2015 Aug 13.
8
Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
Pain Physician. 2008 Mar;11(2 Suppl):S5-S62.
9
Responsible prescribing of opioids for the management of chronic pain.
Drugs. 2003;63(1):17-32. doi: 10.2165/00003495-200363010-00002.
10
Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.
Lancet Public Health. 2018 Jul;3(7):e341-e350. doi: 10.1016/S2468-2667(18)30110-5.
本文引用的文献
1
Nonmedical use of prescription drugs in the European Union.
BMC Psychiatry. 2016 Aug 4;16:274. doi: 10.1186/s12888-016-0909-3.
2
Recommendations for the Prevention, Detection, Treatment and Management of Prescription Opioid Analgesic Dependence: Outcomes From the Opioid Analgesic Dependence Education Nexus (OPEN) Meeting.
Int J Ment Health Addict. 2016;14:313-321. doi: 10.1007/s11469-015-9590-x. Epub 2015 Dec 3.
3
Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies.
BMJ Open. 2016 Jun 20;6(6):e010364. doi: 10.1136/bmjopen-2015-010364.
4
CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49. doi: 10.15585/mmwr.rr6501e1.
5
Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose: A Cohort Study.
Ann Intern Med. 2016 Jan 5;164(1):1-9. doi: 10.7326/M15-0038. Epub 2015 Dec 29.
6
Tolerability and efficacy of tapentadol extended release in elderly patients ≥ 75 years of age with chronic osteoarthritis knee or low back pain.
J Opioid Manag. 2015 Sep-Oct;11(5):393-403. doi: 10.5055/jom.2015.0289.
7
Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.
Pain. 2015 Apr;156(4):569-576. doi: 10.1097/01.j.pain.0000460357.01998.f1.
8
The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.
Ann Intern Med. 2015 Feb 17;162(4):276-86. doi: 10.7326/M14-2559.
9
A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathy.
Diabetes Care. 2014 Aug;37(8):2302-9. doi: 10.2337/dc13-2291. Epub 2014 May 21.
10
Efficacy of tapentadol ER for managing moderate to severe chronic pain.
Pain Physician. 2013 Jan;16(1):27-40.
Zotero 插件